Literature DB >> 7830021

Cost-effectiveness: a new criterion for selecting therapy.

B Jönsson.   

Abstract

Mesh:

Year:  1995        PMID: 7830021     DOI: 10.1111/j.1365-2796.1995.tb01132.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


× No keyword cloud information.
  1 in total

1.  An economic analysis of the Survival and Ventricular Enlargement (SAVE) Study. Application to the United Kingdom.

Authors:  S Hummel; J Piercy; R Wright; A Davie; A Bagust; J McMurray
Journal:  Pharmacoeconomics       Date:  1997-08       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.